Dosidal · Switzerland

Oxaliplatin Fresenius, Konzentrat zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:61679 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 61679
atc: L01XA03
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2011-01-11
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L01XA03
authorisation_number: 61679
form: KOINF
holder: Fresenius Kabi (Schweiz) AG
holder_partner_nr: 1003012
it_number: 07.16.1.
name: Oxaliplatin Fresenius, Konzentrat zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
p2XxXykLzRG0yOM38nm1di7FKfY7IxakgWtP1QG3NbaJQtS24wxntTmIBz3M40HVHEQ_9PTxfy-5E8lqfGPq-A
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:61679 · Related records in other markets · Dosidal